Global Hemorrhagic Stroke Treatment Market 2019-2023

Global Hemorrhagic Stroke Treatment Market 2019-2023

About this market

The improved diagnostic modalities for hemorrhagic stroke recovery to help market grow. For the appropriate management of hemorrhagic stroke, an adequate understanding of parenchymal hemorrhage is crucial. Since intracerebral hemorrhage is an acute clinical manifestation of the underlying cerebral small vessel diseases (cSVDs), it is essential to use improved diagnostic modalities such as MRI markers to monitor the risk stratification. Technavio’s analysts have predicted that the hemorrhagic stroke treatment market will register a CAGR of almost 4% by 2023.

Market Overview

Rising incidence in aging population

Increasing age is a major risk for several conditions, including intracerebral hemorrhages. This increases the demand for drugs thereby pushing growth in the hemorrhagic stroke treatment market.

High generic influx

The patent expiry of most of the products has paved the way for the entry of generics into the market. The excessive use of generic medicine can impede the demand for branded drugs, thereby affecting the market.

For the detailed list of factors that will drive and challenge the growth of the hemorrhagic stroke treatment market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Baxter and Novartis the competitive environment is quite intense. Factors such as the improved diagnostic modalities for hemorrhagic stroke recovery and the rising incidence in aging population, will provide considerable growth opportunities to hemorrhagic stroke treatment manufactures. Baxter, Novartis, Sanofi, and Pfizer are some of the major companies covered in this report.

‘With the presence of a considerable number of companies, this market appears to be fragmented. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.’


  • Executive summary
  • Scope of the report
  • Market landscape
    • Market ecosystem
      • Table Global CNS therapeutics market
      • Table Segments of global CNS therapeutics market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Table Pipeline molecules for hemorrhagic stroke treatment
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • Antihypertensives - Market size and forecast 2018-2023
      • Table Antihypertensives - Market size and forecast 2018-2023 ($ millions)
      • Table Antihypertensives - Year-over-year growth 2019-2023 (%)
    • Anticoagulants - Market size and forecast 2018-2023
      • Table Anticoagulants - Market size and forecast 2018-2023 ($ millions)
      • Table Anticoagulants - Year-over-year growth 2019-2023 (%)
    • Diuretics - Market size and forecast 2018-2023
      • Table Diuretics - Market size and forecast 2018-2023 ($ millions)
      • Table Diuretics - Year-over-year growth 2019-2023 (%)
    • Anticonvulsants and others - Market size and forecast 2018- 2023
      • Table Anticonvulsants and others - Market size and forecast 2018-2023 ($ millions)
      • Table Anticonvulsants and others - Year-over-year growth 2019-2023 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Market segmentation by type
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Americas - Market size and forecast 2018-2023
      • Table Americas - Market size and forecast 2018-2023 ($ millions)
      • Table Americas - Year-over-year growth 2019-2023 (%)
    • APAC - Market size and forecast 2018-2023
      • Table APAC - Market size and forecast 2018-2023 ($ millions)
      • Table APAC - Year-over-year growth 2019-2023 (%)
    • EMEA - Market size and forecast 2018-2023
      • Table EMEA - Market size and forecast 2018-2023 ($ millions)
      • Table EMEA - Year-over-year growth 2019-2023 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
    • Table Interventions for improving drug delivery to BBB
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Baxter
      • Table Baxter - Vendor overview
      • Table Baxter - Business segments
      • Table Baxter - Organizational developments
      • Table Baxter - Geographic focus
      • Table Baxter - Key offerings
    • Novartis
      • Table Novartis - Vendor overview
      • Table Novartis - Business segments
      • Table Novartis - Organizational developments
      • Table Novartis - Geographic focus
      • Table Novartis - Segment focus
      • Table Novartis - Key offerings
    • Pfizer
      • Table Pfizer - Vendor overview
      • Table Pfizer - Business segments
      • Table Pfizer - Organizational developments
      • Table Pfizer - Geographic focus
      • Table Pfizer - Segment focus
      • Table Pfizer - Key offerings
    • Sanofi
      • Table Sanofi - Vendor overview
      • Table Sanofi - Business segments
      • Table Sanofi - Organizational developments
      • Table Sanofi - Segment focus
      • Table Sanofi - Segment focus
      • Table Sanofi - Key offerings
  • Appendix
    • Research methodology
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook